Evidence update: GlaxoSmithKline's inactivated quadrivalent influenza vaccines.
about
Seasonal influenza vaccination in patients with COPD: a systematic literature review.Quadrivalent influenza vaccine: a new opportunity to reduce the influenza burden.Cost-Utility of Quadrivalent Versus Trivalent Influenza Vaccine in Germany, Using an Individual-Based Dynamic Transmission Model.A review of the value of quadrivalent influenza vaccines and their potential contribution to influenza control.Cost-effectiveness analysis of quadrivalent seasonal influenza vaccines in England.Influenza Vaccination in Patients with Common Variable Immunodeficiency (CVID).Influenza surveillance in Western Turkey in the era of quadrivalent vaccines: A 2003-2016 retrospective analysis.
P2860
Q33634938-95D6730D-B311-40ED-8623-9566693EA6C1Q37011571-100E095E-A492-425B-BE11-4A8798145D2DQ37416216-89789B41-0944-4E4D-86D1-84E365FC3478Q39322780-C12E9968-4375-48AD-8C5B-3091F24F9F70Q40052934-DA7A815E-BE7D-48A2-A0D2-D56069186B45Q47853099-BEC45924-78FE-474B-8712-16687E870EE2Q54255449-C4657954-5475-44E3-BFC4-9D694529E0D3
P2860
Evidence update: GlaxoSmithKline's inactivated quadrivalent influenza vaccines.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年学术文章
@wuu
2015年学术文章
@zh-cn
2015年学术文章
@zh-hans
2015年学术文章
@zh-my
2015年学术文章
@zh-sg
2015年學術文章
@yue
2015年學術文章
@zh
2015年學術文章
@zh-hant
name
Evidence update: GlaxoSmithKline's inactivated quadrivalent influenza vaccines.
@en
type
label
Evidence update: GlaxoSmithKline's inactivated quadrivalent influenza vaccines.
@en
prefLabel
Evidence update: GlaxoSmithKline's inactivated quadrivalent influenza vaccines.
@en
P2093
P2860
P1476
Evidence update: GlaxoSmithKline's inactivated quadrivalent influenza vaccines
@en
P2093
Rafik Bekkat-Berkani
Varsha K Jain
Vijayalakshmi Chandrasekaran
P2860
P304
P356
10.1586/14760584.2016.1113878
P577
2015-12-05T00:00:00Z